Cannabis Pharmaceuticals Market Report 2026
Download Free Sample Buy Now
Cannabis Pharmaceuticals Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cannabis Pharmaceuticals Market Report 2026

Global Outlook – By Product Type (Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids), By Therapeutic Application (Cancer, Neurological Disorders, Pain Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Cannabis Pharmaceuticals Market Overview

• Cannabis Pharmaceuticals market size has reached to $9.43 billion in 2025

• Expected to grow to $85.68 billion in 2030 at a compound annual growth rate (CAGR) of 55.3%

• Growth Driver: Increasing Epilepsy Cases Boost Demand For Cannabis-Based Treatments

• Market Trend: Advancing Medical Cannabis Production To Meet Global Demand

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cannabis Pharmaceuticals Market?

Cannabis pharmaceuticals are prescription-grade medications made from cannabis-derived compounds, designed to address particular health conditions and produced under strict clinical and regulatory standards. These pharmaceuticals utilize the therapeutic benefits of cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), to treat conditions including chronic pain, epilepsy, and multiple sclerosis.

The main indications in the cannabis pharmaceuticals include cannabinoid-based pharmaceuticals, cannabis extracts, and synthetic cannabinoids. Cannabinoid-based pharmaceuticals are drugs that incorporate synthetic or natural cannabinoids, such as THC and CBD, to address various health conditions. The various formulation types are capsules and tablets, oils and tinctures, and topical solutions used in therapeutic applications such as cancer, neurological disorders, and pain management. The various distribution channels include hospital pharmacies, online pharmacies, and retail pharmacies and are used by several end users, including hospitals and clinics, rehabilitation centers, and research organizations.

Cannabis Pharmaceuticals Market Global Report 2026 Market Report bar graph

What Is The Cannabis Pharmaceuticals Market Size and Share 2026?

The cannabis pharmaceuticals market size has grown exponentially in recent years. It will grow from $9.43 billion in 2025 to $14.74 billion in 2026 at a compound annual growth rate (CAGR) of 56.3%. The growth in the historic period can be attributed to increasing recognition of therapeutic benefits of cannabinoids, expansion of medical cannabis prescriptions, availability of early cannabis-based drugs, growth of hospital-based pain management programs, regulatory approvals for select cannabis pharmaceuticals.

What Is The Cannabis Pharmaceuticals Market Growth Forecast?

The cannabis pharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $85.68 billion in 2030 at a compound annual growth rate (CAGR) of 55.3%. The growth in the forecast period can be attributed to increasing investments in cannabis drug clinical trials, rising demand for standardized cannabinoid formulations, expansion of neurological and oncology applications, growing adoption of cannabis pharmaceuticals in hospitals, increasing regulatory harmonization across markets. Major trends in the forecast period include increasing development of prescription-grade cannabis medications, rising focus on clinical validation and trials, growing use in neurological and pain disorders, expansion of regulated pharmaceutical pipelines, enhanced emphasis on dosage precision.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Cannabis Pharmaceuticals Market Segmentation

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids

2) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists

What Is The Driver Of The Cannabis Pharmaceuticals Market?

The rise in incidence of epilepsy is expected to drive the cannabis pharmaceuticals market going forward. Epilepsy refers to a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. The rise in epilepsy cases can be attributed to better diagnosis, increased awareness, and enhanced reporting, alongside potential environmental, genetic, and lifestyle influences. Cannabis pharmaceuticals have shown potential in helping manage epilepsy by utilizing cannabinoids like CBD to reduce the frequency and severity of seizures in patients who do not respond well to traditional anti-epileptic drugs. For instance, in February 2024, according to the World Health Organization, a Switzerland-based global health agency, the number of people living with epilepsy worldwide has risen to approximately 50 million in 2024. Therefore, the rise in incidence of epilepsy is driving the growth of the cannabis pharmaceuticals industry.

Key Players In The Global Cannabis Pharmaceuticals Market

Major companies operating in the cannabis pharmaceuticals market are Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.

Global Cannabis Pharmaceuticals Market Trends and Insights

Major companies operating in the cannabis pharmaceuticals market are focusing on developing innovative products such as advanced medical cannabis formulations to address a range of medical conditions and improve patient outcomes. Advanced medical cannabis formulations refer to specially designed cannabis-based products that are optimized for therapeutic use, incorporating precise doses of cannabinoids like THC and CBD. For instance, in April 2024, Canexis Pharma AG, a Switzerland-based pharmaceutical company, received manufacturing and narcotics licenses from Swissmedic for cannabis pharmaceuticals. These approvals empower the company to produce premium-grade medicinal active ingredients derived from CBD and THC. This development positions Canexis to meet the growing demand for medical cannabis both within Switzerland and globally. By obtaining these licenses, the company demonstrates its compliance with stringent regulatory standards, enhancing its credibility and ability to contribute to the rapidly evolving medical cannabis market.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Cannabis Pharmaceuticals Market?

In September 2025, High Tide, a Canada-based cannabis and wellness company, acquired a majority stake in Remexian Pharma GmbH, for an undisclosed amount. With this acquisition, High Tide aims to expand its pharmaceutical and wellness portfolio, enhance its product development capabilities, strengthen its European market presence, and drive long-term growth and strategic synergies. Remexian Pharma GmbH is a Germany-based pharmaceutical company specializing in the development and production of innovative healthcare solutions.

Regional Outlook

North America was the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cannabis Pharmaceuticals Market?

The cannabis pharmaceuticals market consists of sales of dronabinol (synthetic THC) and cannabidiol (CBD) oil used to treat various medical conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cannabis Pharmaceuticals Market Report 2026?

The cannabis pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cannabis Pharmaceuticals Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $14.74 billion
Revenue Forecast In 2035 $85.68 billion
Growth Rate CAGR of 56.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Therapeutic Application, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cannabis Pharmaceuticals Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cannabis Pharmaceuticals Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cannabis Pharmaceuticals Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cannabis Pharmaceuticals Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Fintech, Blockchain, Regtech & Digital Finance

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Development Of Prescription-Grade Cannabis Medications

4.2.2 Rising Focus On Clinical Validation And Trials

4.2.3 Growing Use In Neurological And Pain Disorders

4.2.4 Expansion Of Regulated Pharmaceutical Pipelines

4.2.5 Enhanced Emphasis On Dosage Precision

5. Cannabis Pharmaceuticals Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Rehabilitation Centers

5.3 Pharmaceutical Companies

5.4 Medical Research Institutes

5.5 Specialty Treatment Centers

6. Cannabis Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cannabis Pharmaceuticals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cannabis Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cannabis Pharmaceuticals Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cannabis Pharmaceuticals Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cannabis Pharmaceuticals Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cannabis Pharmaceuticals Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cannabis Pharmaceuticals Market Segmentation

9.1. Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids

9.2. Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cancer, Neurological Disorders, Pain Management

9.3. Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries

9.4. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination Of THC And CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

9.5. Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists

10. Cannabis Pharmaceuticals Market Regional And Country Analysis

10.1. Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cannabis Pharmaceuticals Market

11.1. Asia-Pacific Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cannabis Pharmaceuticals Market

12.1. China Cannabis Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cannabis Pharmaceuticals Market

13.1. India Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cannabis Pharmaceuticals Market

14.1. Japan Cannabis Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cannabis Pharmaceuticals Market

15.1. Australia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cannabis Pharmaceuticals Market

16.1. Indonesia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cannabis Pharmaceuticals Market

17.1. South Korea Cannabis Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cannabis Pharmaceuticals Market

18.1. Taiwan Cannabis Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cannabis Pharmaceuticals Market

19.1. South East Asia Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cannabis Pharmaceuticals Market

20.1. Western Europe Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cannabis Pharmaceuticals Market

21.1. UK Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cannabis Pharmaceuticals Market

22.1. Germany Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cannabis Pharmaceuticals Market

23.1. France Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cannabis Pharmaceuticals Market

24.1. Italy Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cannabis Pharmaceuticals Market

25.1. Spain Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cannabis Pharmaceuticals Market

26.1. Eastern Europe Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cannabis Pharmaceuticals Market

27.1. Russia Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cannabis Pharmaceuticals Market

28.1. North America Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cannabis Pharmaceuticals Market

29.1. USA Cannabis Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cannabis Pharmaceuticals Market

30.1. Canada Cannabis Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cannabis Pharmaceuticals Market

31.1. South America Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cannabis Pharmaceuticals Market

32.1. Brazil Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cannabis Pharmaceuticals Market

33.1. Middle East Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cannabis Pharmaceuticals Market

34.1. Africa Cannabis Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Cannabis Pharmaceuticals Market, Segmentation By Product Type, Segmentation By Therapeutic Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cannabis Pharmaceuticals Market Regulatory and Investment Landscape

36. Cannabis Pharmaceuticals Market Competitive Landscape And Company Profiles

36.1. Cannabis Pharmaceuticals Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cannabis Pharmaceuticals Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cannabis Pharmaceuticals Market Company Profiles

36.3.1. Tilray Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Canopy Growth Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Aurora Cannabis Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Aphria Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Cronos Group Overview, Products and Services, Strategy and Financial Analysis

37. Cannabis Pharmaceuticals Market Other Major And Innovative Companies

GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc.

38. Global Cannabis Pharmaceuticals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cannabis Pharmaceuticals Market

40. Cannabis Pharmaceuticals Market High Potential Countries, Segments and Strategies

40.1 Cannabis Pharmaceuticals Market In 2030 - Countries Offering Most New Opportunities

40.2 Cannabis Pharmaceuticals Market In 2030 - Segments Offering Most New Opportunities

40.3 Cannabis Pharmaceuticals Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Cannabis Pharmaceuticals Market, Overview Of Key Products - Product Examples
  • Table 2: Global Cannabis Pharmaceuticals Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Cannabis Pharmaceuticals Market, Supply Chain Analysis
  • Table 4: Global Cannabis Pharmaceuticals Market, Major Raw Material Providers
  • Table 5: Global Cannabis Pharmaceuticals Market, Major Resource Providers
  • Table 6: Global Cannabis Pharmaceuticals Market, Major Manufacturers (Suppliers)
  • Table 7: Global Cannabis Pharmaceuticals Market, Major Distributors And Channel Partners
  • Table 8: Global Cannabis Pharmaceuticals Market, Key Technologies & Future Trends
  • Table 9: Global Cannabis Pharmaceuticals Market, Major Trends
  • Table 10: Global Cannabis Pharmaceuticals Market, Major End Users
  • Table 11: Global Cannabis Pharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Cannabis Pharmaceuticals Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Cannabis Pharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Cannabis Pharmaceuticals Market - TAM, US$ Billion, 2025
  • Table 15: Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Cannabis Pharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Cannabis Pharmaceuticals Market - Company Scoring Matrix
  • Table 96: Tilray Inc. Financial Performance
  • Table 97: Canopy Growth Corporation Financial Performance
  • Table 98: Aurora Cannabis Inc. Financial Performance
  • Table 99: Aphria Inc. Financial Performance
  • Table 100: Cronos Group Financial Performance
  • Table 101: Global Cannabis Pharmaceuticals Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Cannabis Pharmaceuticals Market, Competitive Dashboard
  • Table 103: Global Cannabis Pharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Cannabis Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 105: Global, Cannabis Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Therapeutic Application, 2025 – 2030
  • Table 106: Global, Cannabis Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Cannabis Pharmaceuticals Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Cannabis Pharmaceuticals Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Cannabis Pharmaceuticals Market, Supply Chain Analysis
  • Figure 4: Global Cannabis Pharmaceuticals Market, Major Raw Material Providers
  • Figure 5: Global Cannabis Pharmaceuticals Market, Major Resource Providers
  • Figure 6: Global Cannabis Pharmaceuticals Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Cannabis Pharmaceuticals Market, Major Distributors And Channel Partners
  • Figure 8: Global Cannabis Pharmaceuticals Market, Key Technologies & Future Trends
  • Figure 9: Global Cannabis Pharmaceuticals Market, Major Trends
  • Figure 10: Global Cannabis Pharmaceuticals Market, Major End Users
  • Figure 11: Global Cannabis Pharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Cannabis Pharmaceuticals Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Cannabis Pharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Cannabis Pharmaceuticals Market - TAM, US$ Billion, 2025
  • Figure 15: Global Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Cannabinoid-Based Pharmaceuticals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Cannabis Pharmaceuticals Market, Sub-Segmentation Of Synthetic Cannabinoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Cannabis Pharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Cannabis Pharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Cannabis Pharmaceuticals Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Cannabis Pharmaceuticals Market, Segmentation By Therapeutic Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Cannabis Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Cannabis Pharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Cannabis Pharmaceuticals Market - Company Scoring Matrix
  • Figure 96: Tilray Inc. Financial Performance
  • Figure 97: Canopy Growth Corporation Financial Performance
  • Figure 98: Aurora Cannabis Inc. Financial Performance
  • Figure 99: Aphria Inc. Financial Performance
  • Figure 100: Cronos Group Financial Performance
  • Figure 101: Global Cannabis Pharmaceuticals Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Cannabis Pharmaceuticals Market, Competitive Dashboard
  • Figure 103: Global Cannabis Pharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Cannabis Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 105: Global, Cannabis Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Therapeutic Application, 2025 – 2030
  • Figure 106: Global, Cannabis Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Cannabis Cultivation Market Report 2026 - Global Outlook – By Type (Cannabis Indica, Cannabis Sativa), By Source (Flower or Buds, Leaves, Other Sources), By Application Outlook  (Medical Consumption, Recreational Consump...

Cannabis Vaporizers Market Report 2026 - Global Outlook – By Type (Portable, Tabletop), By Ingredients (Herbs, Oils, Cannabis Wax), By Heating Method (Conduction, Convection), By Purpose (Medical Purpose, Recreational Pu...

Medical Marijuana Market Report 2026 - Global Outlook – By Product (Dried Flower, Extract Form), By Formulation (Flower, Concentrate, Edibles, Other Types), By Application (Pain Management, Tourette Syndrome, Alzheimer's...

Recreational Cannabis Market Report 2026 - Global Outlook – By Product (Oils, Transdermal Patches, Tablets, Capsule, Vape, Suppositories, Tinctures, Creams, Edibles, Other Products ), By Compound (Tetrahydrocannabinol (T...

Cannabinoids Market Report 2026 - Global Outlook – By Product Type (Cannabidiol, Tetrahydrocannabinol, Cannabinol, Other Product Types), By Distribution (Hospital Pharmacies, Retail Pharmacies, Online Stores ), By Applic...

Cannabis Extract Market Report 2026 - Global Outlook – By Product Type (Oils, Tinctures), By Extract Type (Full Spectrum Extracts, Cannabis Isolates), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Onli...

Cannabis Capsule Market Report 2026 - Global Outlook – By Type (High Tetrahydrocannabinol Capsules, Tetrahydrocannabinol Or Cannabinol Balance Capsule, High Cannabinol Capsules), By Compound (Tetrahydrocannabinol (THC)-D...

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

Frequently Asked Questions

The Cannabis Pharmaceuticals market was valued at $9.43 billion in 2025, increased to $14.74 billion in 2026, and is projected to reach $85.68 billion by 2030.

The global Cannabis Pharmaceuticals market is expected to grow at a CAGR of 55.3% from 2026 to 2035 to reach $85.68 billion by 2035.

Some Key Players in the Cannabis Pharmaceuticals market Include, Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc. .

Major trend in this market includes: Advancing Medical Cannabis Production To Meet Global Demand. For further insights on this market. request a sample here

North America was the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us